Effect of age of Armagnac extract and duration of treatment on antithrombotic effects in a rat thrombosis model

Thrombosis Research

Volumn 111, Issue 3, 2003, Pages 185-189

  Umar, Anwar ^a   Boisseau, Michel ^a   Segur, Marie Claude ^b   Begaud, Bernard ^a   Moore, Nicholas ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b 32800 Eauze   (France)

Author keywords

Armagnac; Arteriovenous shunt thrombosis; In vivo; Oral administration; Polyphenols; Rats

Indexed keywords

ANTICOAGULANT AGENT; ARMAGNAC EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARMAGNAC; ARTERIOVENOUS SHUNT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG RESPONSE; GENERAL CONDITION IMPROVEMENT; MALE; MEDICINAL PLANT; NONHUMAN; PLANT AGE; PRIORITY JOURNAL; RAT; RAT STRAIN; THROMBOSIS; THROMBUS; TIME; TREATMENT OUTCOME; WEIGHT;

EID: 0346849907     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.09.016     Document Type: Article

References (20)

1. Umar A., Guerin V., Renard M., Boisseau M., Garreau C., Begaud B.et al. Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo. Thromb. Res. 110(2-3):2003;135-140.
2. Evans A.E., Ruidavets J.B., McCrum E.E., Cambou J.P., McClean R., Douste-Blazy P.et al. Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse. QJM. 88(7):1995;469-477.
3. Tunstall-Pedoe H., Kuulasmaa K., Mahonen M., Tolonen H., Ruokokoski E., Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 353(9164):1999;1547-1557.
4. Cambou J.P., Richard J.L., Arveiler D., Nuttens M.C., Ruidavets J.B., Bingham A.et al. Primary results of the MONICA project. Rev. Prat. 40(24):1999;2247-2260.
5. Wu J.M., Wang Z.R., Hsieh T.C., Bruder J.L., Zou J.G., Huang Y.Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review). Int. J. Mol. Med. 8(1):2001;3-17.
6. Das D.K., Sato M., Ray P.S., Maulik G., Engelman R.M., Bertelli A.A.et al. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp. Clin. Res. 25(2-3):1999;115-120.
7. DaPorto C., Calligaris S., Celotti E., Nicoli M.C. Antiradical properties of commercial cognacs assessed by the DPPH(·) test. J. Agric. Food Chem. 48(9):2000;4241-4245.
8. Goldberg D.M., Hoffman B., Yang J., Soleas G.J. Phenolic constituents, furans, and total antioxidant status of distilled spirits. J. Agric. Food Chem. 47(10):1999;3978-3985.
9. Shand R.A., Smith J.R., Wallis R.B. Expression of the platelet procoagulant activity in vivo in thrombus formation in an extracorporeal shunt in the rat. Thromb. Res. 36(3):1984;223-232.
10. Umetsu T., Sanai K. Effect of 1-methyl-2-mercapto-5-(3-pyridyl) -imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats. Thromb. Haemost. 39(1):1978;74-83.
11. Smith J.R., White A.M. Fibrin, red cell and platelet interactions in an experimental model of thrombosis. Br. J. Pharmacol. 77(1):1982;29-38.
12. Peters R.F., Lees C.M., Mitchell K.A., Tweed M.F., Talbot M.D., Wallis R.B. The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost. Thromb. Haemost. 65(3):1991;268-274.
13. Armitage P., Berry G., Matthews J.N.S. Statistical methods in medical research. 4th ed. 2002;Blackwell, Oxford.
14. Tukey J.W., Ciminera J.L., Heyse J.F. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics. 41(1):1985;295-301.
15. Gronbaek M., Deis A., Sorensen T.I., Becker U., Schnohr P., Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ. 310(6988):1995;1165-1169.
16. Gronbaek M. Type of alcohol and mortality from cardiovascular disease. Food Chem. Toxicol. 37(9-10):1999;921-924.
17. Ruf J.C., Berger J.L., Renaud S. Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Relation to tannins and lipid peroxidation. Arterioscler. Thromb. Vasc. Biol. 15(1):1995;140-144.
18. Ruf J.C. Wine and polyphenols related to platelet aggregation and atherothrombosis. Drugs Exp. Clin. Res. 25(2-3):1999;125-131.
19. Rand M.L., Groves H.M., Packham M.A., Mustard J.F., Kinlough-Rathbone R.L. Acute administration of ethanol to rabbits inhibits thrombus formation induced by indwelling aortic catheters. Lab. Invest. 63(6):1990;742-745.
20. Demrow H.S., Slane P.R., Folts J.D. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 91(4):1995;1182-1188.